Artane
Artane Price range: $ 48,00 through $ 115,00
Back to products
Asacol
Asacol Price range: $ 62,00 through $ 88,00

Artvigil

Price range: $ 65,00 through $ 398,00

Artvigil is a high-quality generic medication containing Armodafinil, specifically formulated to promote wakefulness and alertness. It is primarily indicated for individuals managing excessive daytime sleepiness associated with narcolepsy. This medication also serves as an effective treatment for persistent sleepiness in patients diagnosed with obstructive sleep apnea. For those working non-traditional hours, Artvigil helps improve wakefulness during scheduled shifts to combat shift work disorder. By targeting specific pathways in the brain, Artvigil assists in maintaining a steady state of mental clarity and focus throughout the day.

Active substance: Armodafinil
SKU: Artvigil Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Artvigil – Information for Patients and Caregivers

Artvigil belongs to a group of central nervous system wakefulness-promoting agents, containing the active drug substance armodafinil. In the United States, armodafinil is classified as a federal Schedule IV prescription medication subject to regulatory oversight. It is prescribed to improve wakefulness in adult patients affected by persistent excessive sleepiness associated with specific sleep-wake conditions.

Proper usage requires a comprehensive clinical evaluation to establish an accurate diagnosis and determine an appropriate treatment plan. Patients taking this medication should remain under the ongoing supervision of a licensed healthcare provider throughout the duration of therapy.

Parameter Details
Active ingredient Armodafinil
Therapeutic class Central nervous system agent; wakefulness-promoting agent
Dosage form Oral tablet
Route of administration Oral
Primary purpose Management of excessive daytime sleepiness
Prescription status Prescription (Rx) / Schedule IV controlled substance
Mechanism of action Selective dopamine reuptake inhibition in specific brain regions

How the drug works

Armodafinil is the isolated R-enantiomer of racemic modafinil, exhibiting a distinct pharmacokinetic profile compared to the racemic mixture. The precise mechanism through which armodafinil promotes wakefulness has not been fully elucidated, but available pharmacological data demonstrate that it binds to dopamine transporters and inhibits dopamine reuptake. This action increases extracellular dopamine concentrations in subcortical brain regions involved in sleep-wake regulation, such as the hypothalamus. Unlike classical central nervous system stimulants, such as amphetamines or methylphenidate, armodafinil does not rely primarily on direct sympathomimetic actions or diffuse neuronal excitation. Consequently, its pharmacological properties yield targeted wake-promoting effects with a lower propensity for severe peripheral cardiovascular activation.

Main uses

Armodafinil is FDA-approved in the United States to treat excessive sleepiness associated with three primary medical diagnoses: obstructive sleep apnea, narcolepsy, and chronic shift work disorder. In patients diagnosed with obstructive sleep apnea, armodafinil is indicated as an adjunct to established airway therapies, such as continuous positive airway pressure (CPAP), rather than a replacement for primary underlying structural management. For individuals with shift work disorder, it addresses sleepiness resulting from non-standard work schedules. Any off-label application, including off-label prescription for cognitive enhancement, attention deficit conditions, or disease-related fatigue, must be evaluated individually by a prescribing clinician based on clinical necessity.

Dosing schedule

Artvigil is administered orally as a single daily dose. For conditions such as narcolepsy and obstructive sleep apnea, the prescribed dose is typically taken once daily in the morning to support daytime alertness and prevent disruption of nocturnal sleep. For patients treated for shift work disorder, the medication is generally taken approximately one hour prior to the start of the work shift. Dosages are determined on an individual basis, taking into account systemic clearance capacity. Patients with severe hepatic impairment require reduced dosages, and lower starting doses are often indicated for elderly patients due to age-related changes in metabolic clearance. Tablets should be swallowed whole with fluid.

What happens in the body

Following oral administration, armodafinil is absorbed efficiently through the gastrointestinal tract, reaching peak plasma concentrations within approximately two to four hours. The pharmacokinetic profile demonstrates dose-proportional linear kinetics across therapeutic range concentrations. Armodafinil exhibits an elimination half-life of approximately 12 to 15 hours, which supports a sustained wake-promoting effect throughout the waking hours with once-daily dosing. The drug is extensively metabolized in the liver via hydrolytic and oxidative pathways, primarily involving the cytochrome P450 enzyme CYP3A4. Less than 10% of the original parent compound is excreted unchanged in the urine, with the remainder eliminated as inactive hepatic metabolites.

Important precautions

Before initiating therapy with Artvigil, prescribers must assess patient medical history for underlying cardiovascular conditions. Armodafinil is not recommended for patients with a history of left ventricular hypertrophy or significant mitral valve prolapse associated with CNS stimulant administration. Pre-existing hypertension and ischemic heart disease require regular clinical monitoring. Psychiatric adverse events, including anxiety, agitation, aggression, mania, or depression, may occur or worsen during treatment. Patients with a history of psychosis or severe mood disorders must be observed closely for behavioral changes. Armodafinil safety in pregnant individuals has not been established; it should be used during pregnancy only if the potential therapeutic benefit outweighs fetal risk. Caution is advised during breastfeeding.

Red flags

Patients taking armodafinil must seek immediate emergency medical care if they experience signs of severe adverse events. Serious dermatological reactions, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported with armodafinil use. Development of a progressive skin rash, peeling, mucosal sores, or unexplained fever requires immediate drug discontinuation and medical evaluation. Emergency attention is also required if patients exhibit hypersensitivity symptoms, such as swelling of the face, lips, tongue, or throat, difficulty swallowing or breathing, severe chest pain, irregular heart rhythms, or severe psychiatric symptoms such as acute hallucinations, severe paranoia, or suicidal thoughts.

Adverse reactions

Clinical trials indicate that armodafinil is generally tolerated, though adverse events do occur. The most commonly reported side effect is headache, followed by nausea, dizziness, insomnia, anxiety, and dry mouth. Most adverse events are mild to moderate in intensity and often diminish over time. However, psychiatric symptoms including irritability, agitation, nervousness, and sleep disturbances may emerge. Patients should monitor for persistent or bothersome symptoms and report them to their prescribing healthcare provider.

Compatibility with other medicines

Armodafinil interacts with hepatic drug-metabolizing enzymes, functioning as a moderate inducer of CYP3A4 and a moderate inhibitor of CYP2C19. Co-administration of armodafinil with hormonal contraceptives–including oral pills, patches, implants, and intrauterine devices–can significantly reduce hormonal systemic exposure, potentially leading to contraceptive failure. Alternative or additional non-hormonal barrier methods of contraception should be utilized during treatment and for one month after stopping armodafinil. Concomitant use with drugs metabolized by CYP3A4 (such as cyclosporine, midazolam, and triazolam) may decrease their therapeutic blood levels. Conversely, co-administration with strong CYP3A4 inhibitors or substrates of CYP2C19 (such as omeprazole, diazepam, and phenytoin) may alter plasma drug concentrations, requiring dosage adjustments.

What to avoid while taking it

Artvigil may be ingested with or without food. However, administration with a high-fat meal may delay the time required to achieve peak plasma concentration by approximately one to two hours, although overall systemic exposure remains unaffected. Patients are strongly advised to avoid consuming alcohol while undergoing treatment with armodafinil. Alcohol consumption can impair central nervous system function, cause unpredictable alterations in cognitive awareness, and heighten the risk of adverse reactions such as dizziness, sedation, or impaired psychomotor coordination.

If you skip a dose

If a dose of Artvigil is missed, the patient should take it as soon as remembered, provided it is still early in their planned waking period. If the missed dose is recalled late in the afternoon or evening, it should be omitted to minimize the risk of severe nocturnal insomnia. Double doses should never be taken to compensate for a missed tablet. Patients should resume their standard prescribed schedule on the following day or before their next scheduled shift.

Storage and expiration

Artvigil tablets must be stored at controlled room temperature, typically between 68°F and 77°F (20°C to 25°C), with brief temperature excursions permitted between 59°F and 86°F (15°C to 30°C). The product should be maintained in its original container to protect the tablets from excessive moisture, direct heat, and light exposure. Always verify the expiration date printed on the packaging prior to use; expired medications must not be consumed and should be disposed of via designated community drug take-back programs or local pharmacy guidelines.

Frequently Asked Questions

Can armodafinil lead to dependence or addiction?

Armodafinil is classified as a Schedule IV controlled substance in the United States due to a potential for abuse or dependence, although its dependence risk is lower than that of Schedule II stimulants like amphetamines. Chronic misuse or high-dose administration can produce psychological reliance. Patients should follow prescribed dosages strictly and avoid altering their regimen without consulting their physician.

Does armodafinil interfere with hormonal birth control?

Yes. Armodafinil induces CYP3A4 hepatic enzymes, which accelerates the breakdown of synthetic hormones found in oral contraceptives, patches, injections, and implants. This interaction significantly decreases contraceptive effectiveness. Females of childbearing potential must use an effective non-hormonal barrier method during treatment and for 30 days after stopping armodafinil.

Is it safe to drive after taking Artvigil?

Although armodafinil is intended to promote wakefulness, it may not completely restore normal levels of alertness in individuals with severe underlying sleep disorders. Furthermore, side effects like dizziness or blurred vision can occur. Patients should evaluate their individual response to the medication before operating motor vehicles or operating heavy machinery.

How does armodafinil differ from conventional central nervous system stimulants?

Unlike traditional stimulants such as methylphenidate or amphetamines, armodafinil does not cause direct, widespread release of catecholamines throughout the nervous system. Instead, it selectively modulates subcortical sleep-wake pathways and dopamine reuptake, resulting in wakefulness enhancement with less peripheral sympathomimetic activity such as severe tachycardia or rebound sedation.

What should I do if armodafinil causes insomnia?

Insomnia is a recognized adverse effect, often related to taking the dose too late in the day. To reduce sleep disturbances, ensure the medication is taken immediately upon waking in the morning (or one hour prior to a work shift for shift work disorder). If insomnia persists despite proper timing, consult your healthcare provider for evaluation.

Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.

In accordance with FDA requirements.

Additional information
Dosage

150 mg

Package

30 pills

,

60 pills

,

100 pills

,

200 pills

,

300 pills

,

500 pills

Ενεργός Ουσία